As respiratory virus season is again expected to begin hitting much of the U.S. in the fall, the Centers for Disease Control and Prevention is taking proactive steps to protect older adults by updating its guidelines for two relatively new RSV vaccines.

The recommendations, for administration of GSK’s Arexvy, Pfizer’s Abrysvo and Moderna’s mRESVIA vaccines, state that everyone aged 75 and older should receive a Respiratory Syncytial Virus vaccination, as should those between 60 and 74 with certain chronic health conditions and/or living in a nursing home. The CDC announced the new guidelines in a Wednesday news release.

CLICK/TAP TO ENLARGE

The updated recommendations follow CDC analyses of RSV burden among people 60 and older, as well as studies on RSV vaccine effectiveness.

"The CDC has updated its RSV vaccination recommendation for older adults to prioritize those at highest risk for serious illness from RSV,” CDC director Dr. Mandy Cohen said in the release.

Advertise with us

The ideal time to get the vaccine is in late summer or the start of fall, per the CDC, before RSV begins its likely resurgence.

RSV causes 60,000-120,000 hospitalizations and 6,000-10,000 deaths in American adults 60 and older yearly, per the American Lung Association.

Unlike some vaccines, such as for COVID-19, the RSV vaccine is not an annual, the CDC noted. That means a dose isn’t given every respiratory virus season, which typically begins in the fall, peaks in the winter and ends in the spring in most of the country.

Dr. Brian Lamb, an internal medicine physician at Allegheny Health Network, said that while likely due to increased testing, he has observed an increase in RSV cases.

“We saw a surge in RSV this late winter — November through January — but it even lingered through February and March, so we were seeing a lot of cases,” he said. “[The vaccine] has been an ongoing conversation since it rolled out last year, and it’s still an ongoing conversation with a lot of patients.”

Advertise with us

Arexvy and Abrysvo were approved by the FDA for adults 60 and up in May 2023.

The new guidelines, Dr. Lamb said, take away a lot of preexisting confusion regarding who should — and who should not — get vaccinated.

“The new guidelines actually make it easier,” said Dr. Lamb. “Before, it was recommended for everyone 60 and above if they had a condition that put them at high risk.”

RSV is a common but highly contagious respiratory virus and causes mild, cold-like symptoms. In infants, children and older adults with heart or lung issues and people with weakened immune systems, RSV can become dangerous and require hospitalization. In some cases, RSV can lead to complications such as middle ear infection, repeated infections, respiratory failure, congestive heart failure, apnea and dehydration, per the Allegheny County Health Department.

Spreading by droplets — such as from coughing or sneezing — the RSV virus can survive for many hours on hard surfaces, and for shorter amounts of time on soft surfaces.

Advertise with us

Symptoms of RSV include runny nose, decrease in appetite, coughing, sneezing, fever and wheezing, which typically start four to six days after infection and last two to eight days. Most healthy individuals recover in one to two weeks without treatment.

The CDC said that health care providers should recommend RSV vaccines to their eligible patients, as well as discuss what other vaccines they will need this fall to help prevent respiratory infections. The RSV vaccine for older adults is available at numerous pharmacies, or patients can ask their primary care physician to administer it.

“I think the biggest thing — based on last year's numbers — if you've already gotten vaccinated, you don't need to worry about getting vaccinated again, but if you haven’t, we encourage everyone to get the vaccine — it’s the best way to keep yourself safe and healthy,” said Dr. Lamb.

Separately, the FDA in 2023 approved the Beyfortus RSV vaccine for infants, which was co-developed by Sanofi and AstraZeneca.

Young infants with RSV may experience irritability, decreased activity and breathing difficulties. Per the Allegheny County Health Department, RSV is the most common cause of bronchiolitis and pneumonia in children less than one year of age.

Ava Dzurenda: adzurenda@post-gazette.com.